ASTRO 2024 | Washington, DC

SCIENTIFIC EVIDENCE

September 29 – October 3, 2024

ORAL Presentations & Invited Talks

SUNDAY, SEPTEMBER 29 3:37 PM \| ROOM 147	Scientific Development and Clinical Deployment of BgRT Murat Surucu, Ph.D., Stanford VIEW HERE
MONDAY, SEPTEMBER 30 3:00 PM \| ROOM 145	Early Clinical Insights into FDG-Guided Radiotherapy Planning and Delivery on a Novel PET-Linac Platform in Patients with Lung and Bone Lesions: Pioneering Real-Time Biology-guided Radiotherapy Bin Cai, Ph.D., UT Southwestern VIEW HERE
MONDAY, SEPTEMBER 30 3:50 PM \| ROOM 145	Feasibility of Biology-guided Radiotherapy with Gallium-68 PSMA-11 Radiotracer for Bony Metastases in Prostate Cancer Patients Chunhui Han, Ph.D., City of Hope VIEW HERE
TUESDAY, OCTOBER 1 8:40 AM \| ROOM 152	Impact of Synthetic PET Evaluation prior to PET-Guided Functional Modeling in Optimizing Patient Selection for Biology-guided Radiotherapy Dan Hicks, M.D., Yale New Haven Health VIEW HERE

FEATURED POSTERS

SUNDAY, SEPTEMBER 29 2:45 PM \| HALL C	Congruence of the Per-Fraction PET Signal and the Delivered Doses in Biology-guided Radiotherapy (BgRT) Daniel Pham, Ph.D., Stanford VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Evaluation of BgRT Delivery Accuracy for Multiple Small Targets of Varying Sizes Murat Surucu, Ph.D., Stanford VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Clinical Implementation of SCINTIX Biology-guided Radiotherapy: A Single Institution Experience from Initial Patient Selection to First SCINTIX Delivery Chunhui Han, Ph.D., City of Hope VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Commissioning of the RefleXion Positron Emission Tomography Guided Radiation Planning and Delivery System William Watkins, Ph.D., City of Hope VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Evaluation of Biology-guided Radiotherapy (BgRT) in Motion Phantom with Real Patient Breathing Patterns Huixiao Chen, Ph.D., Yale New Haven Health VIEW HERE

POSTERS

SUNDAY, SEPTEMBER 29 2:45 PM \| HALL C	Complete vs. Incomplete Consolidative Radiotherapy in Patients with Extensive-Stage Small Cell Lung Cancer James Ninia, M.D., Yale New Haven Health VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Effect of Biodistribution Changes via Increase in Target Size in Biology-guided Radiotherapy (BgRT) Murat Surucu, Ph.D., Stanford VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Biology-guided Radiotherapy (BgRT) Emulated Delivery: Simulating Target Motion Girish Bal, Ph.D., RefleXion VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Evaluation of ¹⁸F-FDG and ¹⁸F-FMISO PET Imaging for Biology-guided Radiotherapy in Lung and Abdomen Cancer Patients Emily Draeger, Ph.D., Yale New Haven Health VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Film Dosimetry Metrics for Biology-guided Radiotherapy (BgRT) Jeffrey Schmall, Ph.D., RefleXion VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Initial Biology-guided Radiotherapy (BgRT) Phantom Design, Characterization and Planning with Multiple Asynchronous Targets for Metastatic Lung Treatment Jeffrey Schmall, Ph.D., RefleXion VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Quantitative Assessment of Tracked Dose Delivery with Biology-guided Radiotherapy (BgRT) Sanchit Sharma, Ph.D., RefleXion VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Feasibility Study of Treating Small Targets with Different PET Uptake Concentration Using BgRT Jina Chang, Ph.D., University of Pittsburgh Medical Center VIEW HERE
SUNDAY, SEPTEMBER 29 4:45 PM \| HALL C	Assessment of Knowledge-Based Plan Optimization for a Clinical PET/CT-LINAC Weili Zhong, Ph.D., Yale New Haven Health VIEW HERE
MONDAY, SEPTEMBER 30 8:00 AM \| HALL C	Feasibility of Biology-guided Radiotherapy for Tumors in the Cervix Using a PET-CT Linac Grant Gibbard, M.S., RefleXion VIEW HERE
MONDAY, SEPTEMBER 30 5:00 PM \| HALL C	A Feasibility Study of Using ⁶⁴Cu-ATSM PET for Radiation Dose Painting Escalation in Locally Advanced Rectal Cancers Dorine de Jong, Ph.D., RefleXion VIEW HERE
TUESDAY, OCTOBER 1 12:45 PM \| HALL C	Preliminary Study on Biology-Guided Radiotherapy Planning for Metastatic Liver Lesions Using a Novel O-Ring PET Linac Platform An Liu, Ph.D., City of Hope VIEW HERE
TUESDAY, OCTOBER 1 2:00 PM \| HALL C	Hypoxia-Guided Dose Escalated Radiation Therapy in Prostate Cancer: A Dosimetric Feasibility Study Dorine de Jong, Ph.D., RefleXion VIEW HERE

SCINTIX THERAPY

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

LEARN MORE

DISCLOSURES

As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.